The Healthcare Technology Report is pleased to announce The Top 25 Healthcare Technology COOs of 2023. In an era where technology holds an influential sway over various domains, the healthcare technology industry's staggering growth to a $2 trillion powerhouse is unsurprising. Healthcare technology encompasses an array of tools – from telehealth to robotic-assisted surgery – geared towards enhancing hospital and administrative efficiency, advancing medical insights, and elevating healthcare quality.
Ensuring the seamless daily functioning of their organizations are Chief Operating Officers (COOs), whose significance lies in their adeptness at optimizing processes, ensuring regulatory compliance, and fostering innovation across diverse departments. This year's roster of COOs represent some of the most successful and innovative in the healthcare technology industry. These men and women have not only adeptly managed their companies' daily functions but have also devised strategic initiatives that propelled their organizations to the pinnacle, ultimately advancing patient care and perpetuating the industry's upward trajectory.
Dave Dookeeram exemplifies a stellar COO, bringing over two decades of expertise in his current position at Pager, a prominent virtual care and tech-enabled services platform. Prior to joining Pager, Dookeeram played a pivotal role in DispatchHealth during its infancy, and his leadership catapulted the company to a valuation exceeding $2 billion.
In a similar role, Daryl Gaugler serves at Pacira. With a distinguished career spanning three decades in the life sciences sector, Gaugler boasts a track record of establishing and guiding over 400 commercial teams and crafting effective go-to-market strategies for more than 20 firms. Meanwhile, Charlotte Donald embarked on her professional journey 22 years ago and currently holds the position of Director of Operations at Cera, Europe's foremost provider of digital-first home healthcare solutions.
Please join us in celebrating The Top 25 Healthcare Technology COOs of 2023.
1. Daryl Gaugler
Company: Pacira Pharmaceuticals
Title: Chief Operating Officer
Daryl Gaugler is COO at Pacira, a leading provider of non-opioid pain management and regenerative health solutions. Founded in 2006 and headquartered in Tampa, FL, Pacira has offices in NJ and California. As COO, Gaugler is responsible for overseeing Sales, Commercial Operations, Reimbursement, Sports Accounts, Health System Alliance, Learning and Development, and Marketing and Communications. Previously, Gaugler served as Senior Vice President of Commercial Operations, a role he held at the company since June 2019.
Prior to joining Pacira, Gaugler spent over 20 years with the Quintiles Transnational organization (now IQVIA), most recently as President of North American Commercial Solutions. Gaugler delivered significant revenue and profit growth while leading customer satisfaction and employee engagement within the organization. He is a seasoned life sciences executive with 30 years of experience in commercial leadership that includes building and directing over 400 commercial teams and designing go-to-market strategies for more than 20 companies. Gaugler holds a BS in Business Administration from Shippensburg University.
2. Ronan Brown
Company: ConcertAI
Title: Chief Operating Officer
Ronan Brown is the COO of ConcertAI, a leader in Real-World Evidence (RWE) and AI technology solutions for life sciences and healthcare. Their mission is to accelerate insights and outcomes for patients through leading real-world data, AI technologies, and scientific expertise in partnership with the leading biomedical innovators, healthcare providers, and medical societies. Brown is a leader in AI SaaS technology and Real-world Evidence (RWE) solutions for life sciences and healthcare. As the ConcertAI’s first ever COO, he oversees and enhances day-to-day operations across the company.
Before joining ConcertAI, Brown was the head of decentralized trials solutions at IQVIA. Before that, he served as an executive director at NovaQuest. Earlier in his career, he worked with GlaxoSmithKline as an international study team leader. Brown graduated from the University of London with a Ph.D. and from the University of Southampton with an undergraduate degree in biochemistry and physiology.
3. Vanessa Lemarié
Company: Ada Health
Title: Chief Operating Officer
Vanessa Lemarié is the COO of Ada Health, a global health company created by doctors to improve human health by transforming knowledge into better outcomes. Ada is the world's most popular symptom assessment and care navigation app, and also integrates its technology into third party environments and campaigns to today serve more than 13 million app users, over 50 million users in an Enterprise setting, and several of the world's largest healthcare companies among its clients. Every three seconds, someone turns to Ada for personal health guidance.
Serving as both Chief Operating and Chief Client Officer, Lemarié is responsible for leading Business Development, Commercial Operations, Client Success, Market Access & Health Policy, Marketing and Communications, Operations & Project Management, Legal, as well as People, Culture & Workplace.
Prior to joining Ada, Lemarié has led marketing and commercial teams at Bayer Pharmaceuticals for 15 years in positions of growing responsibility in country, regional, and global roles. Lemarié graduated from Maastricht University with a Drs./MS in International Business and holds an undergraduate degree in economics and political science from Stellenbosch University.
4. Dave Dookeeram
Company: Pager
Title: Chief Operating Officer
Dave Dookeeram is the COO of Pager, a leading virtual-care, tech-enabled services platform that engages, guides and connects people to access the right care, in the right place, at the right time with a trusted, personalized "doctor-in-the-family" experience. Notably, Dookeeram has over 20 years of experience driving profitable growth for health tech companies, medical groups, and hospitals. Before joining Pager, he served as President of Diagnostics and Chief of Staff at DispatchHealth, an in-home high-acuity medical provider. Dookeeram joined DispatchHealth in the seed stage and served as a key executive through explosive growth to over 75 cities and $100 million in revenue. Under his leadership, the company surpassed a $2 billion valuation.
Prior to that, Dookeeram served as the COO at Centura Health's Porter Adventist Hospital, where he drove EBITDA from $7 million to $42 million in four years and attained national rankings in multiple specialties. In addition, Dookeeram is the incoming board chair of Christian Living Communities/Capella Living Solutions. He is Board Certified in Healthcare Management by the American College of Healthcare Executives (FACHE). Dookeeram is board-certified in healthcare management and holds a master's in healthcare administration and policy from Emory University and a bachelor's degree from Dartmouth College.
5. Eric Davidson
Company: Eko
Title: President and Chief Operating Officer
Eric Davidson joined Eko in February of 2022 as President and COO. Eko Health is a leading innovator in digital health technology for heart and lung disease detection. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect disease earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible.
Prior to joining Eko, Davidson held the position of President, Flexible Robotics, at Johnson & Johnson (formerly Auris Health, Inc.). Prior to Auris, Davidson spent nine years at Intuitive Surgical in marketing with his last position as Vice President of Product Marketing. Davidson began his medical device career at Stryker Endoscopy, holding various roles in sales and marketing. He holds an MBA from the Stanford Graduate School of Business and a BA from Pomona College.
6. Kathryn Corzo
Company: Bit.bio
Title: President & Chief Operating Officer
Kathryn Corzo is the President and COO of bit.bio, an award-winning human synthetic biology enterprise. Notably, Corzo is a highly regarded biotechnology executive with extensive experience in early and late drug development across multiple indications and platforms. Most recently, she was a partner at Takeda Ventures; and previously served as Head of Oncology Cell Therapy Development at Takeda Pharmaceuticals, where she built capabilities and oversaw a cutting edge oncology cell therapy portfolio. She also served on Takeda’s R&D Management Committee, was a member of Takeda’s Oncology Leadership Team and served on the board of directors for Maverick Therapeutics which was acquired by Takeda in March 2021.
Previously, Corzo was Sanofi Genzyme’s Vice President R&D Myeloma Head, where she led global registration programs to drug approvals in the US, EU and Japan. In addition, she held various R&D leadership roles at Hoffmann-La-Roche, Roche Molecular Systems, Eli Lilly and Syndax, contributing to the initial approval of 6 innovative cancer medicines and multiple indication expansions across the globe. Corzo graduated from MIT Sloan School of Management with an MBA and from Massachusetts College of Pharmacy and Health Sciences with an undergraduate degree in pharmacy.
7. Kathy Ford
Company: Kura Oncology
Title: Chief Operating Officer
Kathy Ford is the COO of Kura Oncology, a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Their small-molecule drug candidates target signaling pathways and other drivers of cancer where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment. Ford has more than 30 years of biopharmaceutical experience supporting pipeline development.
She was most recently Senior Vice President, Head of Global Clinical Operations, at Merck Serono, a division of Merck KGaA, where she led clinical and development operations toward successful drug registrations in both the U.S. and Europe. Previously, she served in roles of increasing responsibility at Millennium Pharmaceuticals, most recently as Vice President, Clinical Operations, where she led the global operational management of clinical trial activities in all phases of development. Prior to that, she served as Director of Clinical Operations at Alkermes, where she managed the clinical development for two product approvals. Ford earned her R.N. from Massachusetts General Hospital School of Nursing and her B.S.N. from Fitchburg State College.
8. Brendan Teehan
Company: Acadia Pharmaceuticals Inc.
Title: EVP and Chief Operating Officer
Brendan Teehan is the EVP and COO of Acadia Pharmaceuticals, a company that is advancing breakthroughs in neuroscience to elevate life. For 30 years they have been working at the forefront of healthcare to bring vital solutions to people who need them most. They developed and commercialized the first and only approved therapies for hallucinations and delusions associated with Parkinson’s disease psychosis and for the treatment of Rett syndrome. Teehan joined Acadia from TESARO, where he served as Vice President, building and leading the company’s first provider support function designed to help oncologists optimize patient care.
Over the course of his career, Teehan has led field sales, operations and marketing teams in the U.S. and Europe – and successfully launched small and large molecule products. He began his career with Johnson & Johnson, where he held a variety of commercial roles across numerous therapeutic categories, including oncology, immunology, inflammation, transplantation, chronic obstructive pulmonary disease and asthma. Teehan earned an MBA from Carnegie Mellon University and a BA in Government and International Relations from Notre Dame.
9. Chris Williams
Company: Cytek Biosciences
Title: Chief Operating Officer
Chris Williams is the COO of Cytek Biosciences, a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling™ (FSP™) technology. Cytek’s novel approach harnesses the power of information within the entire spectrum of a fluorescent signal to achieve a higher level of multiplexing with precision and sensitivity. Cytek is headquartered in Fremont, California with offices and distribution channels across the globe.
Prior to joining Cytek, Williams served as VP of engineering, technology, operations and innovation for Thermo Fisher’s Pharma Services Group. Before that, he was vice president and general manager for single use technologies and vice president and general manager for bioprocess equipment and automation – both at Thermo Fisher Scientific. He also served as vice president of site engineering for Bayer Pharmaceuticals Division. Williams holds a BS in Mechanical Engineering from the University of Texas at Austin.
10. Michael Haynie
Company: Osso VR
Title: Senior Vice President of Operations
Michael Haynie is an accomplished healthcare executive and the Senior Vice President of Operations at Osso VR. With a distinguished career rooted in advancing care quality and innovation, she has been instrumental in solidifying Osso's position as the world's leading provider of virtual reality medical training solutions.
Haynie has a wealth of strategic management experience, having previously served as Managing Director at the National Quality Forum (NQF). Prior to NQF, she held senior leadership positions at healthcare organizations including StayWell, Optum and The Advisory Board Company. Haynie is a graduate of Harvard University with a BA in Anthropology.
Michael Haynie's Insight
"It’s been incredibly rewarding to witness the growth and success of Osso VR, where we're not just influencing the future of medical training; we're re-writing the playbook,” said Michael Haynie, SVP of Operations for Osso VR. “As clinical evidence continues to demonstrate, Osso VR is revolutionizing the surgical training experience and driving a new era of excellence, accessibility and standardization on a global scale.”
11. Thomas Holmes
Company: Amylyx Pharmaceuticals
Title: Chief Technology Operations Officer
Thomas Holmes is the Chief Technology Operations Officer at Amylyx Pharmaceuticals, a company that is committed to supporting and creating more moments for the neurodegenerative disease community through the discovery and development of innovative new treatments. Amylyx is headquartered in Cambridge, Massachusetts and has operations in Canada and EMEA.
Holmes joined Amylyx in 2019 as Global Head of Supply Chain, bringing to the company more than 25 years of leadership experience in supply chain, biopharmaceutical manufacturing, and program management. Prior to joining Amylyx, Haynie was the Senior Director of External Manufacturing at Biogen Inc., a role he held for 10 years. Tom received a BS in Business Administration with a concentration in Management from Salem State University.
12. Chris Brown
Company: Hc1
Title: Chief Operating Officer
Chris Brown is the COO of hc1, the leader in identifying real-time insights from complex laboratory data. Hc1 solutions optimize laboratory operations for thousands of locations and inform testing and treatment decisions for millions of patients. Over more than 10 years, flagship hc1 solutions, now known as hc1 Performance Analytics™ and hc1 Operations Management™, have helped forge a broad set of lab and health system partnerships with their ability to unlock actionable, real-time insights to increase efficiency and reduce costs.
Previously, Brown spent 20 years scaling technology businesses in the wireless sector. He held various leadership roles in sales and customer operations, finance, M&A, and strategic planning for Verizon Wireless and Nextel Communications. At Nextel, he was part of the team that completed the $35 billion merger with Sprint – and then completed the $7 billion follow-on acquisition of Nextel Partners. Brown started his career at Deloitte Haskins and Sells and is a CPA. Brown graduated from Moravian University with an undergraduate degree in accounting.
13. Shawn Campbell
Company: Synaptive Medical
Title: Senior Vice President of Operations
Shawn Campbell is Senior Vice President of Operations at Synaptive Medical, a global medical device and technology company operating in 15 countries to solve surgical, imaging and data challenges. In his current role, Campbell leads a cross functional team of 85 people covering Field Services, Clinical Applications, IT and Security, Facilities, Manufacturing, and Supply Chain. His role touches upon product lifecycle support, driving growth, customer experience, process efficiencies, and overseeing the smooth operations of these departments to make the organization’s activities streamlined and efficient. Prior to joining Synaptive in December 2021, Campbell served as VP Operations at KA Imaging; and also as VP Operations at Neurolign Technologies.
Prior to these roles, Campbell spent 25 years with the General Electric Company, where he served in a variety of roles, including leadership roles in GE’s Industrial and Automation businesses as a Field Service Representative and Business Development Manager across a variety of marketplaces. At GE Healthcare, he held leadership roles in the areas of services, applications, project management, supply chain, aftermarket sales and marketing. Campbell also oversaw key business initiatives such as driving productivity across a global service portfolio and leveraging AI principles in advanced remote troubleshooting for service. He is a graduate of Humber College.
Shawn Campbell's Insight
“I am proud to receive this recognition for being part of an innovative and passionate team of people that continuously push the boundaries to develop the most advanced technology supporting healthcare practitioners in achieving positive outcomes for their patients. Supporting our customers, helping to guide a rapidly growing company, and working with such talented people, brings me great pride and makes for an extremely fulfilling professional life.”
14. Amara Siva
Company: Epic Sciences
Title: Senior Vice President of Laboratory Operations
Amara Siva is the Senior Vice President of Laboratory Operations at Epic Sciences, a company that is developing novel diagnostics to guide therapy selection and monitor disease progression, personalizing and advancing the treatment and management of prostate and breast cancer. The company’s liquid biopsy platform leverages proven, proprietary cell analysis capabilities as well as cell-free analysis to provide more efficient analysis and clearer insights. Notably, Siva has over 20 years of molecular diagnostic development experience.
Prior to joining Epic Sciences, Siva served in leadership roles at companies such as Pathnostics, Millennium Health, Genoptix/Novartis, Gen-Probe, and Alexion. Siva received her B.S. in Biochemistry and Cell Biology from UC San Diego and Ph.D. in Biological Chemistry from UCLA. She is an ASQ-certified Six Sigma Green Belt, holds a Clinical Genetic Molecular Biologist Scientist license in the State of California, and is certified as a High-complexity Clinical Laboratory Director by the American Board of Bioanalysis.
15. Andrea Oster
Company: Notable
Title: Chief Operating Officer
Andrea Oster is the COO of Notable Growth, a specialized Martech consultancy that works with companies on building and maintaining best-in-class marketing experiences. She previously helped scale a mobile product agency from a start-up of two to a mobile product consultancy with 60 employees between Mumbai and Brooklyn. Responsible for strategy, operations, and talent company-wide, Oster is particularly skilled at creating cultures and establishing processes that help employees collaborate efficiently and happily.
Oster got her MBA in digital strategy from NYU Stern, where she was also a teaching fellow for bestselling author Scott Galloway. Previously, she also worked in luxury retail at De Beers and Georg Jensen – and at branding and e-commerce agencies. She continues to draw from those experiences as she oversees partnerships with start-ups and Fortune500 companies alike.
16. Daniel Davis
Company: Imperative Care
Title: Chief Operating Officer
Daniel Davis is the COO of Imperative Care, a Silicon Valley-based medical technology company researching and developing connected innovations to elevate care for people affected by devastating vascular diseases such as stroke and pulmonary embolism. The company has four businesses focused on addressing specific gaps in treatment and care. Davis joined Imperative Care in 2020 and brings 19 years of experience in sales, marketing, and business development – with both early stage and Fortune 500 companies.
Prior to joining Imperative Care, Davis was Chief Commercial Officer and President, North America for Penumbra. He joined Penumbra in 2007 in the pre-commercial phase to launch the first FDA cleared intracranial delivery catheter (Neuron), the first FDA cleared aspiration system for neurovascular mechanical thrombectomy (Penumbra System), and the Penumbra Coil 400 for the treatment of intracranial aneurysms. Previously, he held sales and marketing positions of increasing responsibility at Boston Scientific (now Stryker Neurovascular) as well as roles at Newell Rubbermaid and Trilogy. Davis holds an AB in History and in Economics from Duke University.
17. Shou Bai Chao
Company: CanSino Biologics Inc.
Title: Chief Operating Officer
Shou Bai Chao is the COO at CanSinoBIO, an innovative biopharmaceutical company dedicated to exploring best solutions to the prevention of diseases through cutting-edge research & development, advanced manufacturing and commercialization of innovative vaccine products for human use worldwide. Since its establishment in Tianjin, China in 2009, CanSinoBIO has experienced tremendous growth with 17 vaccines preventing 12 diseases.
An industry veteran, Chao began his career in 1993. Before joining CanSino Biologics, he was an SVP of bioventures at AstraZeneca. Before that, he served as an assistant VP at Pfizer. Earlier in his career, he worked with Sanofi-pasteur, Toronto, Canada as a head of drug substance manufacturing and technical operations. Chao graduated from the University of Waterloo with a Ph.D. and from the Chinese Academy of Sciences with an undergraduate degree in biotechnology.
18. Wenkang Qi
Company: VitalConnect
Title: Chief Operating Officer
Wenkang Qi is the COO at VitalConnect, a leader in wearable biosensor technology. Its technology is routinely used for cardiac monitoring as well as patient monitoring in the hospital and at home. VitalConnect leverages extensive expertise in biomedical engineering, data analytics, chip design, and mobile and cloud software to create technology that supports decision-making paradigms that achieve better health and economic outcomes. Notably, Qi has over 20 years of experience in medical device development, manufacturing and commercialization.
Prior to joining VitalConnect, Qi was the COO at BAROnova, leading the operations for the development of an implantable PMA weight loss device. Prior to that, Qi was the CTO and VP of R&D at Clarity Medical Systems. Qi’s extensive experience includes VP of R&D at Asante Solutions, where he developed and launched an innovative insulin pump; VP of R&D and Engineering of VasoNova (acquired by Teleflex); and Director of Transducer / Project / Mechanical at Zonare, (acquired by Mindray). Qi started his career with GE Medical Systems, where he earned his Six Sigma Black Belt. Qi has a B.S. and M.S. from Tsinghua University and a Ph.D. from Penn State – with all degrees in Biomedical Engineering.
19. Gordon Hensley
Company: SRTX
Title: Chief Operating Officer
Gordon Hensley is the COO at SRTX. He first joined the company in 2021 as VP of operations. SRTX builds new materials and software to enable better textiles. SRTX is best known for its first technology, Sheertex, a knit made from one of the world's strongest polymers which has disrupted hosiery through impossibly strong pantyhose. Hensley is a senior executive with broad international experience, including substantial profit and loss (P&L) accountability and responsibility for up to 1,500 employees.
Hensley has successfully worked with private equity firms, including the integration of acquisitions and divestiture of operations and the successful management of challenging day-to-day operations. Previously, he was a president of global belt operations at Dayco and before that a director of global engineering at Magna Powertrain. Earlier in his career, he worked with Ricardo Inc. as a chief engineer. Hensley earned an undergraduate degree in mechanical engineering from the University of Leeds.
20. Maggie Hanlon
Company: Luma Health
Title: Director of Engineering Operations
Maggie Hanlon is the Director of Engineering Operations at Luma Health. Luma's Patient Success Platform™ integrates with more than 80 EHRs to give staff and clinicians a fuller view of the patient with less manual outreach. With Luma, healthcare organizations see an average of 37% more referred patients in the first six months, and achieve a 39% average revenue increase. Notably, Hanlon has over 10 years managing digital projects and leading multi-disciplinary teams.
Before joining Luma Health, Hanlon was a technical project manager at The Michener Institute of Education at UHN. Before that, she served as a senior project analyst, IT transformation team at University Health Network. Earlier in her career, she worked with Island Medical Program, University of Victoria as a facilities assistant. Hanlon graduated from the University of Toronto with an MS and from the University of Victoria with an undergraduate degree in health information science.
Luma Health's Insight
“Luma offers a comprehensive Patient Success Platform that enables health care organizations to utilize workflows to support patients, before and after receiving care. Across Luma we work continuously to provide Luma Bedrock™ to our clients - our Bedrock best practices are based on 8 years of data, enabling organizations to set their patients up for success in their care journeys.”
21. Jay Baucom
Company: Alphanumeric Systems
Title: Senior Vice President of Global Operations and CIO
Jay Baucom began his professional career 27 years ago. Today, he is the Senior Vice President of Global Operations and CIO at Alphanumeric Systems, a leading life science and healthcare organization. Their teams are driven to improve and enhance interpersonal and patient experiences across industries. Notably, Baucom is an executive leader providing Strategic vision for Digital Transformation of services and solutions, leveraging Intelligent Automation, AI, Digital Learning, and Managed Workplaces.
Baucom got his start in 1996 as a senior business systems analyst at Static Control Components. From there, he went on to Affiliated Computer Services, a Xerox Company, before eventually rising to CIO at North Carolina Community College System, his most recent position prior to joining Alphanumeric Systems. Baucom graduated from Appalachian State University with an undergraduate degree in finance.
22. Michael Raven
Company: ATAI Life Sciences
Title: Senior Vice President Operations
Michael Raven is the Senior Vice President of Operations at ATAI Life Sciences. He first joined the company in 2022. ATAI Life Sciences is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Founded in 2018 as a response to the significant unmet need and lack of innovation in the mental health treatment landscape, atai is dedicated to acquiring, incubating, and efficiently developing innovative therapeutics to treat depression, anxiety, addiction, and other mental health disorders.
Prior to joining atai, Raven gained significant experience at Bayer Pharmaceuticals as Chief-of-Staff & Head of Communications in Product Supply; and as Head of Strategy for the Radiology Business. Prior to that, he managed strategic projects in the medical devices and biotech sector as part of his role as Engagement Manager within McKinsey & Co. Raven holds a bachelor’s in management from WHU in Vallendar and a biotech engineering Diploma from the Technical University in Berlin. He also graduated from the Berlin Doctoral Program in Economics and Management Science. In parallel to his studies, he co-founded two biotech start-ups.
23. Mary Godwin
Company: Nautilus Biotechnology
Title: Senior Vice President of Operations
Mary Godwin is the Senior Vice President of Operations at Nautilus Biotechnology. With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine.
Godwin is a proven Operations and Supply Chain executive with deep experience across large corporations and smaller start ups. Before joining Nautilus, Godwin held similar roles at Qumulo and Isilon Systems, where she built and scaled an operations function that supported over $1 billion in annual revenue. Prior experience included senior operational roles at Apple, Philips Electronics, and Lucent Technologies. She holds a BS in Plastics Engineering from the University of Massachusetts Lowell, and an MBA from Santa Clara University.
24. Charlotte Donald
Company: Cera
Title: Director of Operations
Charlotte Donald began her professional career 22 years ago. Today, she is the Director of Operations at Cera, Europe's largest provider of digital-first home healthcare, delivering care, nursing, telehealth and repeat prescriptions, with over 50,000 patient appointments a day. Cera's mission is to empower patients to live longer, better lives in the comfort of their own homes, saving the need to go to hospital. Cera's revenue has grown 100-fold in less than three years, making it one of the fastest-growing businesses in Europe.
Donald responsible for the Care Operations within Cera Care. This includes day to day delivery of safe services, quality service delivery, overseeing the running of our contracts with key stakeholders and overseeing the financial sustainability of the business. Donald first got her start in 2001 as a waking night support worker at Craegmoor Healthcare. From there, she went on to Aitch Care Homes, before eventually rising to regional director at City and County Healthcare, her most recent position prior to joining Cera.
25. Jacquelyn Martin
Company: ConforMIS
Title: Director Sales Operations
Jacquelyn Martin is the Director Sales Operations at ConforMIS. She first joined the company in 2020. The company does something that they believe no other knee implant manufacturer has done: they put the patient at the center of implant design. By combining advanced 3D imaging technology with the latest manufacturing capabilities, they manufacture each and every implant based on each patient’s unique size and shape.
Previously, Martin was a director and sales and commercial ops at GNS Healthcare. Before that, she served as a director of sales operations at Conformis. Earlier in her career, she worked with DSM as a sales and marketing analyst. Martin earned an MBA from Boston College Carroll School of Management and an undergraduate degree from Virginia Commonwealth University.
